FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2040976499> ?p ?o ?g. }

• W2040976499 endingPage "757" @default.
• W2040976499 startingPage "750" @default.
• W2040976499 abstract "Acute administration of mitochondrial adenosine triphosphate-dependent potassium channel openers preconditions the heart, but whether their long-term administration induces a permanent state of protection is unknown. These studies investigate the effect of long-term treatment with the mitochondrial adenosine triphosphate-dependent potassium channel opener nicorandil on the response of the human myocardium to ischemia and preconditioning.Right atrial tissue obtained from patients regularly treated with or without nicorandil (mean of 20 mg/d for 18.6 +/- 2.5 months) and undergoing cardiac surgery was sliced and equilibrated for 30 minutes and then subjected to 90 minutes of simulated ischemia, followed by 120 minutes of reoxygenation. In study 1 the following groups were studied to investigate the effect of nicorandil on the susceptibility of the myocardium to ischemia and on the protective effect of ischemic and pharmacologic preconditioning: (1) aerobic control; (2) simulated ischemia and reoxygenation alone; (3) ischemic preconditioning with 5 minutes of simulated ischemia and 5 minutes of reoxygenation; and (4) phenylephrine (0.1 micromol/L) for 5 minutes and 5 minutes' washout before simulated ischemia and reoxygenation. In study 2 the following groups were studied to investigate the effect of nicorandil on the responsiveness of mitochondrial adenosine triphosphate-dependent potassium channels: (1) aerobic control; (2) simulated ischemia and reoxygenation; (3) ischemic preconditioning; (4) diazoxide (100 micromol/L) for 10 minutes before simulated ischemia and reoxygenation, and (5) 5-hydroxydecanoate (1 mmol/L) for 10 minutes before simulated ischemia and reoxygenation. In study 3 the following groups were included to investigate the effect of the long-term administration of nicorandil on the kinase pathway involved in preconditioning: (1) aerobic control; (2) simulated ischemia and reoxygenation alone; (3) ischemic preconditioning; (4) phorbol 12-myristate 13-acetate (1 micromol/L), a protein kinase C activator, for 10 minutes before simulated ischemia and reoxygenation; and (5) anisomycin (1 nmol/L), a p38 mitogen-activated protein kinase activator, for 10 minutes before simulated ischemia and reoxygenation. At the end of each protocol, the leakage of creatine kinase (in units per gram wet weight) and the reduction of 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide into insoluble formazan dye (in millimoles per gram wet weight) were measured.In study 1 the leakage of creatine kinase and the reduction of 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide induced by simulated ischemia and reoxygenation were similar in the groups with or without nicorandil (creatine kinase, 3.4 +/- 0.1 and 3.5 +/- 0.2, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 74.6 +/- 3.9 and 67.9 +/- 7.3, respectively; P >.2 in each instance). Ischemic preconditioning and pharmacologic preconditioning protected the myocardium from patients without nicorandil (creatine kinase, 2.3 +/- 0.1 and 2.4 +/- 0.1, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 131.4 +/- 4.9 and 128.4 +/- 5.6, respectively; P < 0.001 vs simulated ischemia and reoxygenation alone in each instance) but not the myocardium from patients receiving nicorandil (creatine kinase, 3.3 +/- 0.1 and 3.3 +/- 0.2, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 89.7 +/- 6.5 and 86.4 +/- 5.2, respectively; P >.2 vs simulated ischemia and reoxygenation alone in each instance). In study 2 the administration of diazoxide had identical protection to that of ischemic preconditioning in the myocardium of patients not receiving nicorandil (creatine kinase, 2.1 +/- 0.2 and 2.3 +/- 0.1, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 141.4 +/- 7.4 and 131.4 +/- 4.9, respectively; P < 0.001 vs simulated ischemia and reoxygenation alone in each instance) but failed to precondition the myocardium from patients treated with nicorandil (creatine kinase, 3.3 +/- 0.2 and 3.4 +/- 0.1, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 90.1 +/- 7.2 and 86.4 +/- 5.2, respectively; P > 0.2 vs simulated ischemia and reoxygenation alone in each instance). In study 3 phorbol 12-myristate 13-acetate or anisomycin given for 10 minutes before simulated ischemia and reoxygenation afforded similar protection to that of ischemic preconditioning in the myocardium from patients with (creatine kinase, 1.5 +/- 0.3 and 1.4 +/- 0.1, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 147.0 +/- 4.9 and 160.0 +/- 16.1, respectively; P < 0.001 vs simulated ischemia and reoxygenation alone in each instance) and without nicorandil (creatine kinase, 1.7 +/- 0.4 and 1.4 +/- 0.2, respectively; 3-[4,5 dimethylthiazol-2-yl]-2,5 diphenyltetrazolium bromide, 160.3 +/- 13.6 and 158.3 +/- 11.8, respectively; P <.001 vs simulated ischemia and reoxygenation alone in each instance).The myocardium of patients chronically treated with nicorandil cannot be preconditioned either by ischemia or pharmacologically, and this is because of unresponsive mitochondrial adenosine triphosphate-dependent potassium channels. However, protection can be obtained by protein kinase C and p38 mitogen-activated protein kinase activation, which are downstream of mitochondrial adenosine triphosphate-dependent potassium channels in the signaling transduction pathway of preconditioning." @default.
• W2040976499 created "2016-06-24" @default.
• W2040976499 creator A5019408818 @default.
• W2040976499 creator A5027440693 @default.
• W2040976499 date "2002-10-01" @default.
• W2040976499 modified "2023-10-18" @default.
• W2040976499 title "Long-term administration of nicorandil abolishes ischemic and pharmacologic preconditioning of the human myocardium: Role of mitochondrial adenosine triphosphate–dependent potassium channels" @default.
• W2040976499 cites W1970944108 @default.
• W2040976499 cites W1970988487 @default.
• W2040976499 cites W1975705594 @default.
• W2040976499 cites W1980307873 @default.
• W2040976499 cites W1986011506 @default.
• W2040976499 cites W2029676102 @default.
• W2040976499 cites W2038890366 @default.
• W2040976499 cites W2054474511 @default.
• W2040976499 cites W2060171297 @default.
• W2040976499 cites W2062971532 @default.
• W2040976499 cites W2077363968 @default.
• W2040976499 cites W2079683778 @default.
• W2040976499 cites W2083460698 @default.
• W2040976499 cites W2124027170 @default.
• W2040976499 cites W2129167542 @default.
• W2040976499 cites W2135289666 @default.
• W2040976499 cites W2136037597 @default.
• W2040976499 cites W2151668796 @default.
• W2040976499 cites W2166551078 @default.
• W2040976499 cites W2314816455 @default.
• W2040976499 cites W97712012 @default.
• W2040976499 doi "https://doi.org/10.1067/mtc.2002.126037" @default.
• W2040976499 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12324733" @default.
• W2040976499 hasPublicationYear "2002" @default.
• W2040976499 type Work @default.
• W2040976499 sameAs 2040976499 @default.
• W2040976499 citedByCount "21" @default.
• W2040976499 countsByYear W20409764992012 @default.
• W2040976499 countsByYear W20409764992015 @default.
• W2040976499 countsByYear W20409764992017 @default.
• W2040976499 countsByYear W20409764992019 @default.
• W2040976499 crossrefType "journal-article" @default.
• W2040976499 hasAuthorship W2040976499A5019408818 @default.
• W2040976499 hasAuthorship W2040976499A5027440693 @default.
• W2040976499 hasBestOaLocation W20409764991 @default.
• W2040976499 hasConcept C126322002 @default.
• W2040976499 hasConcept C164705383 @default.
• W2040976499 hasConcept C2776991684 @default.
• W2040976499 hasConcept C2777194220 @default.
• W2040976499 hasConcept C2778902376 @default.
• W2040976499 hasConcept C2779306644 @default.
• W2040976499 hasConcept C2779311647 @default.
• W2040976499 hasConcept C2779564974 @default.
• W2040976499 hasConcept C2779872217 @default.
• W2040976499 hasConcept C42219234 @default.
• W2040976499 hasConcept C541997718 @default.
• W2040976499 hasConcept C71924100 @default.
• W2040976499 hasConcept C83743174 @default.
• W2040976499 hasConcept C98274493 @default.
• W2040976499 hasConceptScore W2040976499C126322002 @default.
• W2040976499 hasConceptScore W2040976499C164705383 @default.
• W2040976499 hasConceptScore W2040976499C2776991684 @default.
• W2040976499 hasConceptScore W2040976499C2777194220 @default.
• W2040976499 hasConceptScore W2040976499C2778902376 @default.
• W2040976499 hasConceptScore W2040976499C2779306644 @default.
• W2040976499 hasConceptScore W2040976499C2779311647 @default.
• W2040976499 hasConceptScore W2040976499C2779564974 @default.
• W2040976499 hasConceptScore W2040976499C2779872217 @default.
• W2040976499 hasConceptScore W2040976499C42219234 @default.
• W2040976499 hasConceptScore W2040976499C541997718 @default.
• W2040976499 hasConceptScore W2040976499C71924100 @default.
• W2040976499 hasConceptScore W2040976499C83743174 @default.
• W2040976499 hasConceptScore W2040976499C98274493 @default.
• W2040976499 hasIssue "4" @default.
• W2040976499 hasLocation W20409764991 @default.
• W2040976499 hasLocation W20409764992 @default.
• W2040976499 hasOpenAccess W2040976499 @default.
• W2040976499 hasPrimaryLocation W20409764991 @default.
• W2040976499 hasRelatedWork W1968678384 @default.
• W2040976499 hasRelatedWork W2006430022 @default.
• W2040976499 hasRelatedWork W2009503477 @default.
• W2040976499 hasRelatedWork W2034315096 @default.
• W2040976499 hasRelatedWork W2067567122 @default.
• W2040976499 hasRelatedWork W21463425 @default.
• W2040976499 hasRelatedWork W2258846356 @default.
• W2040976499 hasRelatedWork W2290153811 @default.
• W2040976499 hasRelatedWork W2352554497 @default.
• W2040976499 hasRelatedWork W2430991331 @default.
• W2040976499 hasVolume "124" @default.
• W2040976499 isParatext "false" @default.
• W2040976499 isRetracted "false" @default.
• W2040976499 magId "2040976499" @default.
• W2040976499 workType "article" @default.